#inhibitor — Thursday, October 01, 2026 (1 items)
| 1 | ℹ |
Development of A10P3C, an isoform-selective inhibitor of EGLN2, for targeting breast cancer.
(pnas.org)
|
PNAS 2026-10-01 | #cancer #inhibitor #drug discovery #transcriptomics #selectivity |